financetom
Business
financetom
/
Business
/
Harris would raise corporate tax rate to 28 percent, her campaign says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Harris would raise corporate tax rate to 28 percent, her campaign says
Aug 19, 2024 1:06 PM

WASHINGTON (Reuters) -U.S. Vice President Kamala Harris would raise the corporate tax rate to 28% from 21% if she wins a Nov. 5 election against Republican rival Donald Trump, her campaign said on Monday.

Harris campaign spokesman James Singer said the move would be part of "a fiscally responsible way to put money back in the pockets of working people and ensure billionaires and big corporations pay their fair share."

When Trump was president, he slashed the corporate tax rate to 21% from 35% and implemented other tax breaks that are set to expire next year. Trump has vowed to make the cuts permanent.

Harris, a Democrat, has pledged to maintain President Joe Biden's promise not to raise taxes on people who make $400,000 or less a year.

In an economic policy speech last week, Harris outlined proposals to cut taxes for most Americans, ban "price gouging" by grocers and build more affordable housing as part of the "opportunity economy" she plans to pursue if she wins the White House.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Akero Therapeutics Insider Sold Shares Worth $2,243,213, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $2,243,213, According to a Recent SEC Filing
Mar 6, 2025
02:48 AM EST, 03/06/2025 (MT Newswires) -- Jonathan Young, Chief Operating Officer, on March 04, 2025, sold 50,000 shares in Akero Therapeutics ( AKRO ) for $2,243,213. Following the Form 4 filing with the SEC, Young has control over a total of 261,147 common shares of the company, with 201,147 shares held directly and 60,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017025033998/xslF345X05/ownership.xml...
Novartis not panicking over potential US pharmaceutical tariffs, chairman says
Novartis not panicking over potential US pharmaceutical tariffs, chairman says
Mar 6, 2025
ZURICH, March 6 (Reuters) - Novartis is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the drug maker's Chairman Joerg Reinhardt said in an interview published on Thursday. President Trump last month flagged potential import duties of about 25% on pharmaceuticals as part of measures affecting other industries, including semiconductors and automobiles, as...
Advanced Energy Industries Insider Sold Shares Worth $2,155,137, According to a Recent SEC Filing
Advanced Energy Industries Insider Sold Shares Worth $2,155,137, According to a Recent SEC Filing
Mar 6, 2025
02:50 AM EST, 03/06/2025 (MT Newswires) -- Eduardo Bernal Acebedo, Executive Vice President and Chief Operations Officer, on March 03, 2025, sold 19,309 shares in Advanced Energy Industries ( AEIS ) for $2,155,137. Following the Form 4 filing with the SEC, Acebedo has control over a total of 19,822 common shares of the company, with 19,822 shares held directly. SEC...
SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing
SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing
Mar 6, 2025
02:51 AM EST, 03/06/2025 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on March 03, 2025, sold 20,000 shares in SpringWorks Therapeutics ( SWTX ) for $1,084,592. Following the Form 4 filing with the SEC, Edris has control over a total of 169,712 common shares of the company, with 169,712 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465925021008/xslF345X05/tm258294-2_4seq1.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved